General issues related to health care and pharmaceuticals; drug pricing; patent reform; Medicare issues, including drug price negotiations; FDA issues; FTC issues; H.R.8267 - Old Drugs, New Cures Act
Literal federal measure citations: H.R.8267
2026 · 1st Quarter (Jan 1 - Mar 31)
BAUSCH HEALTH COMPANIES
Filed by BAUSCH HEALTH COMPANIES.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Termination
- Posted
- Apr 16, 2026
- Income
- Not reported
- Expenses
- $330,000.00
- Registrant
- BAUSCH HEALTH COMPANIES
- Client
- BAUSCH HEALTH COMPANIES
- Filing UUID
- f68ce6ad-6d02-48d1-93c2-8e34d6445ed3
- Termination date
- Mar 31, 2026
Expense method: A
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.